par Garcia, Bruno 
;Su, FUHONG ;Dewachter, Laurence ;Favory, Raphaël;Khaldi, Amina ;Moiroux-Sahraoui, Alexander ;Annoni, Filippo ;Vasques-Nóvoa, Francisco;Rocha-Oliveira, Estela;Roncon-Albuquerque, Roberto;Hubesch, Geraldine ;Njimi, Hassane ;Vincent, Jean Louis ;Taccone, Fabio ;Creteur, Jacques ;Herpain, Antoine
Référence Critical care, 26, 1, page (281)
Publication Publié, 2022-09-01
;Su, FUHONG ;Dewachter, Laurence ;Favory, Raphaël;Khaldi, Amina ;Moiroux-Sahraoui, Alexander ;Annoni, Filippo ;Vasques-Nóvoa, Francisco;Rocha-Oliveira, Estela;Roncon-Albuquerque, Roberto;Hubesch, Geraldine ;Njimi, Hassane ;Vincent, Jean Louis ;Taccone, Fabio ;Creteur, Jacques ;Herpain, Antoine Référence Critical care, 26, 1, page (281)
Publication Publié, 2022-09-01
Article révisé par les pairs
| Résumé : | Angiotensin II is one of the vasopressors available for use in septic shock. However, its effects on the septic myocardium remain unclear. The aim of the study was to compare the effects of angiotensin II and norepinephrine on cardiac function and myocardial oxygen consumption, inflammation and injury in experimental septic shock. |
